Serabi heads into full-year results with upgraded reserves
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Serabi Gold reports its full-year 2025 results on 1 May — tomorrow — and the company has handed investors an unusually constructive data point ahead of that release.
On 28 April, just days before the full-year print, Serabi published an updated mineral resource and reserve statement. Consolidated measured and indicated resources rose to 731,000 ounces of gold, with inferred resources adding a further 653,000 oz. For a sub-$350m market-cap gold miner running a single Brazilian mine complex, that is a material lift to the asset base. The stock has gained 21% over the past month — gold's strong run has provided a generous tailwind — though it gave back roughly 2% this week to close at 132p (GBp), slipping further 1.5% on Wednesday alone.
The positioning data tells a story of almost complete disinterest from short sellers, which is actually the most interesting structural feature right now. Short interest is negligible — just 0.007% of the free float, down from a peak of around 0.021% in early April. Availability is effectively uncapped at 9,999% of short interest, meaning the lending pool is vastly larger than the tiny borrowed position. Borrowing costs have eased sharply too: cost to borrow has fallen to 7.2%, down nearly 40% on both a one-week and one-month basis after holding near 12% for most of March and early April. The ORTEX short score is a moderate 31.4, and the lending market reads as entirely loose. There is no short-side pressure here.
The valuation picture is genuinely striking for a profitable gold miner. The EV/EBITDA multiple has compressed to 2.1x — down more than 0.2x over the past month — placing Serabi among the cheapest gold producers by this measure. The factor score for EV/EBIT ranks in the 96th percentile of the universe, confirming the deep-value read. The P/E ratio is 3.0x. Days-to-cover ranks in the 92nd percentile, reflecting very low short positioning relative to trading volumes. The mean analyst price target is 644p — roughly double the current share price of 132p (trading in pence). That gap warrants a caveat: the stock trades on AIM in pence, and analyst coverage is thin, so the target figure may blend different reporting conventions or reflect a small and potentially dated sample. Treat it directionally rather than precisely.
Institutional ownership is concentrated and has been shifting. Starboard Asset Ltda. is the dominant holder at just under 25% of shares, and added nearly 3.8 million shares in the April reporting period. Hargreaves Lansdown and Aberdeen Group both trimmed positions — the former cutting 1.8 million shares, the latter 820,000. Ruffer, a macro-oriented UK manager, reduced by 400,000 shares. The net picture is one of some rotation: the largest strategic shareholder added meaningfully, while several UK wealth managers lightened. Total institutional holders numbered 96 as of 1 April.
Earnings reactions from the past year have been modest. The Q3 production release last November generated a +9.8% one-day move — the largest in the recent sample. The April 2026 Q4 report produced a flat one-day reaction, though the stock drifted fractionally higher over five sessions. The May 1 full-year print arrives alongside the freshly upgraded resource statement, a combination that raises the informational content of tomorrow's release well above the typical quarterly production update. Whether the full-year financials confirm the operational momentum implied by the reserve upgrade is the number to watch.
Stocks in this article
See the live data behind this article on ORTEX.
Open SRB on ORTEX →How this article was generated
- Generated
- 30 Apr 2026, 11:54
- Data as of
- 30 Apr 2026, 11:53
- Prompt version
- v1.0
- Data sources
- Cost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.